Mirouze D, Zipser R D, Reynolds T B
Hepatology. 1983 Jan-Feb;3(1):50-5. doi: 10.1002/hep.1840030108.
The effect of inhibitors of prostaglandin synthesis on diuretic action was examined in patients with ascites due to chronic liver disease and in normal subjects. In patients with ascites, natriuresis after 80 mg i.v. furosemide was reduced 82% by pretreatment with indomethacin. Creatinine clearance was reduced only 16%. These effects were likely due to inhibition of renal prostaglandin synthesis, since urinary prostaglandin E2 fell and there was also reduction in natriuresis with naproxen (52%). The effects were not specific for furosemide since spironolactone-induced natriuresis was also reduced by indomethacin (82%), naproxen (52%), and aspirin (33%). In normal subjects, indomethacin reduced furosemide natriuresis by only 14% while creatinine clearance was not affected. The mechanisms of these drug interactions are uncertain but probably involve renal hemodynamics which appear to be supported importantly by renal prostaglandins in patients with ascites due to liver disease.
在患有慢性肝病腹水的患者和正常受试者中,研究了前列腺素合成抑制剂对利尿作用的影响。在腹水患者中,静脉注射80mg呋塞米后的利钠作用,经吲哚美辛预处理后降低了82%。肌酐清除率仅降低了16%。这些作用可能是由于肾前列腺素合成受到抑制,因为尿前列腺素E2下降,并且萘普生(52%)也使利钠作用降低。这些作用并非呋塞米所特有,因为螺内酯诱导的利钠作用也被吲哚美辛(82%)、萘普生(52%)和阿司匹林(33%)降低。在正常受试者中,吲哚美辛仅使呋塞米的利钠作用降低14%,而肌酐清除率未受影响。这些药物相互作用的机制尚不确定,但可能涉及肾血流动力学,在患有肝病腹水的患者中,肾血流动力学似乎主要由肾前列腺素支持。